Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer.
Mao
C
C
Liao
R-Y
RY
Chen
Q
Q
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D015179:Colorectal Neoplasms / Q000276:immunology / Q000556:secondary* / Q000628:therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D015201:Meta-Analysis as Topic; D051059:PTEN Phosphohydrolase / Q000172:deficiency*; D011379:Prognosis
D000911:Antibodies, Monoclonal; C512478:EGFR protein, human; D066246:ErbB Receptors; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human